atropine has been researched along with elliptinium in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (elliptinium) | Trials (elliptinium) | Recent Studies (post-2010) (elliptinium) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 135 | 8 | 1 |
| Protein | Taxonomy | atropine (IC50) | elliptinium (IC50) |
|---|---|---|---|
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.205 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.7 | |
| Fibroblast growth factor receptor 3 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burtin, C; Eschalier, A; Lavarenne, J; Tounissou, P | 1 |
1 other study(ies) available for atropine and elliptinium
| Article | Year |
|---|---|
Acute hemodynamic effects of an antitumoral agent: elliptinium. Involvement of histamine release.
Topics: Alkaloids; Animals; Antineoplastic Agents; Aspirin; Atropine; Blood Pressure; Cardiovascular Physiological Phenomena; Cimetidine; Coronary Circulation; Dogs; Ellipticines; Female; Heart Rate; Hemodynamics; Histamine Release; Male; Myocardial Contraction; Propranolol; Pyrilamine | 1986 |